|Articles|March 13, 2021

Omega-3 Fatty Acids and Their Impact on COVID-19

Author(s)Killian Meara

Discussing the link between risk of death from SARS-CoV-2 and levels of Omega-3.

Omega-3 is an essential fatty acid which cannot be made from the body. It can be found in many foods such as plant oils, nuts, flaxseeds and seafoods. They are an important component of cell membranes and are associated with a lower risk of several diseases.

In a pilot study published in the journal Prostaglandins, Leukotrienes and Essential Fatty Acids, investigators provided the first bits of evidence that individuals with higher levels of omega-3 in their blood may potentially be at a reduced risk of dying from COVID-19.

In a conversation with two of the lead authors, William Harris, PhD, a professor of internal medicine at the University of South Dakota and Michael Myers, MD, a physician at the Los Alamitos Medical Center, they discuss the important findings from their study.

“What we found was that people in the highest quartile of Omega-3s, 1 person died, and in the lower 3 quartiles, 13 people died,” Harris said. “ When we did the statistics, we found that it wasn’t quite statistically significant by standard metrics, but it was very close to it.”

“It is most likely very real, we're working on trying to do a larger and more detailed study to confirm everything,” Myers said.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.